CMC Invest sees AUD 6.08 target for Regis Healthcare stock
Published on 10/20/2026 at 22:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Six ratings indicated an AUD 6.08 target on October 12, 2026.
- Fiscal year 2026 revenue rose 16.00 percent to AUD 1.35 billion.
- Regis Healthcare stock costs EUR 2.85 at Lang & Schwarz on October 20, 2026.
- The annual general meeting is scheduled for November 17, 2026.
Regis Healthcare (ISIN AU000000REG6) stock is being assessed against an AUD 6.08 average target from six analyst ratings. On October 12, 2026, The Motley Fool reported that CMC Invest had compiled the ratings. Against the ASX price of AUD 4.61 at the October 20, 2026 close, the target stands 31.89 percent above the price. Regis Healthcare was trading at EUR 2.85 at Lang & Schwarz on October 20, 2026 at 10:17 p.m. CEST.
Revenue rose 16.00 percent
The operating backdrop is defined by fiscal year 2026 revenue of AUD 1.35 billion, an increase of 16.00 percent from the previous fiscal year. The same report cited underlying earnings before interest, taxes, depreciation and amortization of AUD 138.00 million and underlying net profit after tax of AUD 55.00 million for that period.
The Motley Fool also noted that Regis Healthcare serves more than 10,000 older Australians through residential aged care, home care and related services.
Price sits above AUD 3.85
The ASX quote closed at AUD 4.61 on October 20, 2026, with a daily range of AUD 4.53 to AUD 4.64. The 52-week range was AUD 3.85 to AUD 8.20, placing the price 19.74 percent above the low and 43.78 percent below the high. The stock's year-to-date return was 31.40 percent, compared with 1.18 percent for the S&P/ASX 200.
Valuation meets November 17 date
Regis Healthcare had a market capitalization of AUD 1.40 billion and a trailing price-to-earnings ratio of 25.61 on October 20, 2026. The indicated dividend yield was 4.11 percent, while the ex-dividend date was September 8, 2026, according to Yahoo Finance.
The next dated corporate event is the annual general meeting on November 17, 2026. Kapitales Research reported that shareholders will vote on executive remuneration arrangements, board matters and the fiscal year 2026 remuneration report.
Comparison with peers
Regis Healthcare (ASX, AUD): up 0.88 percent, price-to-earnings ratio 25.61, market capitalization AUD 1.40 billion.
Ramsay Health Care (ASX, AUD): down 1.64 percent, price-to-earnings ratio 39.78, market capitalization AUD 12.50 billion.
Charter Hall Group (ASX, AUD): down 0.16 percent, price-to-earnings ratio 26.47, market capitalization AUD 9.14 billion.
Analyst target sets the frame
The AUD 6.08 average target sits 31.89 percent above the October 20 ASX price, while the current euro quotation remains separate from that Australian valuation. The upcoming meeting adds a dated governance checkpoint to the revenue and earnings figures.
The further course of trading is shown by the continuously updated real-time quote of Regis Healthcare stock.
Regis Healthcare at a glance
- Company: Regis Healthcare Limited
- ISIN: AU000000REG6
- Ticker: REG
- Primary exchange: ASX
- Price Lang & Schwarz (as of October 20, 2026, 10:17 p.m. CEST): EUR 2.85
- Market capitalization: AUD 1.40 billion (as of October 20, 2026)
- 52-week range: AUD 3.85-8.20 (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical Care Facilities
Market context: Market report S&P/ASX 200.
